Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Titel:
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Auteur:
Buti, Maria Gane, Edward Seto, Wai Kay Chan, Henry L Y Chuang, Wan-Long Stepanova, Tatjana Hui, Aric-Josun Lim, Young-Suk Mehta, Rajiv Janssen, Harry L A Acharya, Subrat K Flaherty, John F Massetto, Benedetta Cathcart, Andrea L Kim, Kyungpil Gaggar, Anuj Subramanian, G Mani McHutchison, John G Pan, Calvin Q Brunetto, Maurizia Izumi, Namiki Marcellin, Patrick